Novo CEO pressed by Senate to chop costs of being overweight, diabetic issues drugs CEO Lars Fruergaard Jørgensen advised lawmakers the corporation would contemplate new talks with insurers about the record rates of Wegovy and copyright should they pledge to keep the medicines on their formularies. The deal must be https://messiahtmiea.timeblog.net/66481966/the-smart-trick-of-healthcare-news-that-nobody-is-discussing